The symptoms Australian women actually talk about: an analysis of 465 verified reviews

Hot flushes are still the symptom Australian women name most — but mood is running a close second, ahead of sleep. We analysed 465 verified customer reviews left on mypause.com between March 2025 and August 2026 to see which midlife symptoms women actually talk about, in their own words. This is the first analysis of its kind we're aware of from an Australian menopause brand's own customer base. In September 2026 we added a second dataset: a survey of 99 of our customers on what happens before women get help — how long they waited, what they tried first, and who they told.

Which menopause symptom do Australian women mention most?

We looked at the 189 verified reviews of Hormone Balance Plus — our broadest product, so the least biased read on which symptoms are front of mind. 135 of them (71%) name at least one specific symptom area. Among those 135:

• Hot flushes & night sweats — 60 reviews (44%)
• Mood, anxiety & irritability — 45 reviews (33%)
• Sleep — 41 reviews (30%)
• Energy & fatigue — 34 reviews (25%)
• Bloating & digestion — 31 reviews (23%)
• Weight & body shape — 26 reviews (19%)
• Brain fog & memory — 20 reviews (15%)

The headline isn't that hot flushes lead — that matches the clinical literature. It's the gap that doesn't exist behind them. Mood is mentioned in a third of symptom-naming reviews, nearly as often as the symptom menopause is famous for. If public conversation about menopause is mostly about hot flushes, the private conversation — what women write when nobody's editing them — gives almost equal weight to irritability, anxiety and mood swings.

Is it usually just one symptom?

No — and this may be the most useful number on this page. Of the women who name any symptom, 61% name two or more, and 24% name three or more. "Hot flushes" or "poor sleep" alone is the exception; the norm is a cluster — sleep plus mood, flushes plus fatigue plus brain fog. That matches what women tell us in support conversations: the hard part of perimenopause is rarely one symptom, it's the pile-up. It's also why we built the range as a system rather than a single pill.

What about sleep?

When we widen the lens to all 465 verified reviews across the full range, sleep becomes the most-mentioned topic of all — it appears in 19% of every review we hold, more than any other single theme. Women write about waking at 3am, about the difference a full night makes to the following day, about sleep being the thing that unravels everything else. If you're navigating this yourself, our guide to non-melatonin sleep support covers the topic in depth.

How do women describe it in their own words?

The language itself is data. Two phrases recur across the corpus with striking consistency:

• "Feeling like myself again" — variations of this phrase ("more like myself", "my old self", "me again") appear in 4% of all reviews. The goal women describe is rarely the absence of a symptom; it's the return of an identity.
• "Game changer" — appears in 5% of reviews, the single most common evaluative phrase in the corpus.

And the way symptoms are described is more vivid than any clinical checklist: "the inner rage", "snapping at everyone over the little things", "the 2–3am wakeups". Perimenopause, in the words of the women living it, is as much an emotional event as a physical one.

How long do women wait before getting help?

In September 2026 we surveyed our customers about the part of the story nobody measures: what happened before they got help. 99 women answered six questions — anonymously, with no incentive offered. What they told us:

• 59% waited a year or more before doing anything about their symptoms. 31% waited two years or more, and 13% waited more than five.
• Only 4% acted almost straight away.
• 37% knew almost nothing about perimenopause until it happened to them — and 74% knew little or nothing beyond having heard the word.
• 21% told no one at all about their symptoms — not a GP, not a partner, not a friend.
• Almost one in five (19%) listed "nothing — I just put up with it" among the first things they tried.
• 7% said they're still not sure their symptoms are "worth acting on".

Read together with the review data above, a picture forms: the same women who can name their symptoms vividly once they understand them spent, in most cases, more than a year not knowing what was happening or whether it warranted help. The wait isn't indifference — it's a knowledge gap. Most women in our survey learned what perimenopause involves only by living it. If that's where you are now, our plain-language guide to perimenopause vs menopause and our guide to how supplements and HRT fit together are written for exactly that moment — and either way, your GP is the right first conversation.

How we ran this analysis

Dataset 1 — review analysis. Data source: customer reviews collected on mypause.com via post-purchase review request emails, exported 13 August 2026. Sample: n = 465 reviews from verified buyers, dated 6 March 2025 to 13 August 2026. We excluded all reviews not tied to a verified purchase. The sample includes every verified review regardless of rating — 13% of the corpus rates 3 stars or below — and includes reviews we chose not to publish on product pages. Average review length: 236 characters. Method: keyword and phrase matching across review titles and bodies, grouped into seven symptom areas (hot flushes/night sweats; sleep; mood/anxiety/irritability; energy/fatigue; weight/body shape; bloating/digestion; brain fog/memory). A review counts once per symptom area regardless of how often it mentions it. Symptom-share percentages for the flagship product are calculated against the 135 reviews naming at least one symptom area; topic percentages for the full range are calculated against all 465. 66% of reviewers received a next-order voucher for leaving a review; the voucher is offered for any honest review, positive or negative.

Dataset 2 — customer survey. Fielded 3–14 September 2026 by email invitation to MyPause customers. n = 99 complete responses. Six multiple-choice questions covering time before acting, first steps tried, prior knowledge of perimenopause, who they first told, current life stage and age range. Anonymous; no incentive was offered. Two questions allowed multiple selections, so those percentages can sum to more than 100. Respondents skew toward women in menopause and post-menopause, aged 50 and over.

Disclosures and limitations: both datasets come from self-selected MyPause customers, not a representative sample of Australian women, and review counts skew toward our highest-selling products. This page reports what women wrote and reported about their own experience — it is not a clinical study, and it is not evidence that any product treats or prevents the symptoms mentioned. If symptoms are affecting your life, talk to your GP.

Updates: we re-run these analyses quarterly as new reviews and survey responses come in. This version reflects review data to 13 August 2026 and survey data to 14 September 2026. Questions about the data: support@mypause.com.

Analysis and page by the MyPause team, led by founder Kathryn Carter.